Clinical Trials Search | Clareo Health

Showing 1-2 of 2 trials

Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma

NCT06909877

This study is a an open-label, multinational, multicenter, single-arm Phase Ⅰb/Ⅱ Study to Evaluate Efficacy and Safety of Oral HH2853 in Patients with Relapsed/Refractory Peripheral T-cell Lymphoma.

Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)

Haihe Biopharma Co., Ltd.100 participantsStarted Jul 2022

Chengdu, Chengdu, China

RECRUITINGPHASE1/PHASE2

A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL

NCT06855823

This is a phase I/II clinical trial to evaluate the efficacy and safety of Golidocitinib combined with Pomalidomide for relapsed/refractory peripheral T-cell lymphoma.

Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)

Sun Yat-sen University33 participantsStarted Jan 2025

Guangzhou, Guangdong, China

Data from ClinicalTrials.govTerms

Filters

Filters

Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma

A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL

Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma

A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL